| | Germany's Bayer said the next U.S. lawsuit scheduled to be heard over claims that its glyphosate-based weedkiller Roundup, causes cancer would likely be postponed. | | | Thailand delivered 4,500 bottles of cannabis oil to treat hospital patients on Wednesday, its first official use of marijuana for medical purposes since a measure legalizing such use took effect this year. | | | Gilead Sciences Inc hopes to soon introduce a pricey new pill to prevent HIV in people at risk of contracting the infection, but the drugmaker faces opposition from an unusual source: patient advocates. | | | Novo Nordisk said on Tuesday it had bought a factory in North Carolina that would assist in manufacturing and packaging its new once-daily pill for treating type 2 diabetes. | | | Bulgaria has failed to contain the spread of African swine fever, its deputy agriculture minister said on Wednesday amid concerns that the Black Sea country could lose its entire 600,000 pig breeding industry. | | | A federal judge late on Tuesday again blocked Arkansas from enforcing a new ban on abortions after 18 weeks of pregnancy, a law that had been expected to go into effect on Wednesday after a previous judicial block expired, CNN and other media reported. | | | China has banned imports of pigs, wild boars and related products from Slovakia to prevent the spread of African swine fever from the European country, China's customs said on Wednesday. | | | AstraZeneca said on Wednesday its cancer drug, Lynparza, was successful in helping patients with metastatic prostate cancer and certain genetic mutations live longer without the disease worsening, compared with the standard of care. | | | The U.S. Food and Drug Administration said on Tuesday that some data from early testing of Novartis' more than $2 million gene therapy Zolgensma was manipulated, but the agency believes the treatment should remain on the market. | | | Walgreens Boots Alliance Inc said on Tuesday it plans to close about 200 U.S. stores and expects to record related pre-tax charges of between $1.9 billion and $2.4 billion. | | | (Reuters Health) - Many patients who receive assistance from charities set up to defray prescription drugs costs may already have insurance that covers most the cost for their medications, a U.S. study suggests. | | | | |